Institutional investors purchased a net $3.5 million shares of OPK during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 23.46% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DAVENPORT & CO. LLC Bought 22.0 Thousand shares of OPKO Health Inc
AMI ASSET MANAGEMENT CORP. Bought 12.8 Thousand shares of OPKO Health Inc
EQIS CAPITAL MANAGEMENT, INC. Bought 11.4 Thousand shares of OPKO Health Inc